ZITICIN

This brand name is authorized in Nigeria.

Active ingredients

The drug ZITICIN contains one active pharmaceutical ingredient (API):

1	Azithromycin UNII 5FD1131I7S - AZITHROMYCIN DIHYDRATE
	Azithromycin is a macrolide antibiotic belonging to the azalide group. The molecule is constructed by adding a nitrogen atom to the lactone ring of erythromycin A. The mechanism of action of azithromycin is based upon the suppression of bacterial protein synthesis by means of binding to the ribosomal 50S sub-unit and inhibition of peptide translocation.
	Read more about Azithromycin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A11-100799	Tablet	Ziticin-Azithromycin Tablets 500 mg TAB 500 mg 1 x 10's (in Alu-PVC blister)	Film Coated Tablet White color, 17 x 8 mm oval shape, plain on both sides ZITICIN -AZITHROMYCIN TABLETS 500MG AZITHROMYCIN TABLETS 500MG AZITHROMYCIN 500mg, Maize Starch, Magnesium Stereate, PvPk30, Microcrystalline Celluose Powder, Sodum STrach Glycolate, Citric Acid, Aerosil Drugs ANTIINFECTIVES FOR SYSTEMIC USE Nigerian Products 1X10 POM 1 7/10/2024 ARTEMIS LABORATORIES LTD, PLOT 4, BLOCK 4, OGUN STATE HOUSING CORPORATION AND INDUSTRIAL ESTATE, OTA, Ado-Odo/Ota, OGUN 8033198927 regulatoryaffairs@artemislife.com Artemis Laboratories Limited, Plot 4, Block 4, Ogun State Housing Corporation and Industrial Estate, Ota, Ogun State, Nigeria, Nigeria	30/01/2025

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01FA10	Azithromycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FA Macrolides
Discover more medicines within J01FA10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A11-100799